PHARMULATOR

PharmCADD CO., LTD.

Trademark Registered: 2022-01-18
Trademark Application Details
Trademark Logo PHARMULATOR
630
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Research OneLook Acronym Finder
Serial Number79303409
Registration Number6617249
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form

Timeline

2020-12-07Application Filed
2021-02-04Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM)
2021-02-04Status: Live/Pending
2021-02-08Transaction Date
2022-01-18Trademark Registered

Trademark Applicants & Owners

Owner: PharmCADD CO., LTD.
Address#221, 222, 2F, APEC-ro 17, Haeundae-gu Busan KR
Legal Entity TypeCorporation
Legal Entity State KR

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

FIRSTLAW P.C.
19F, Dongwon F&B Building,
60 Mabang-Ro,
Seoul
REPUBLIC OF KOREA

Good, Services, and Codes

International Codes:42
U.S. Codes:100,101
Type CodeType
GS0421Design and development of virtual reality software; scientific and technological services; scientific laboratory services; protein analysis; development of devices for protein analysis; design of devices intended for protein analysis; database design and development; scientific research conducted using databases; molecular analysis; development of devices for molecular analysis; development of computer software for big data processing; technical consultancy relating to data analysis for biotechnological applications; technical consultancy relating to computer software development for biotechnological applications; biotechnological research; biochemical analysis; software as a service; providing PaaS [platform as a service]; providing artificial intelligence based computer software technical support services in the field of drug discovery; drug discovery services; research in the field of pharmacogenetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; clinical trials in medicines; hosting a website featuring medical information; design of medical diagnostic apparatus and instruments; computer services for remote data management of medical diagnostic instruments; providing computer software technical support services in the field of medical diagnostics; research for medical products; consulting on the test/inspection/research of medical products; research and development of computer software platforms in the field of artificial intelligence; development of software for artificial intelligence services; conducting clinical trials for others [scientific research]; updating and maintenance of computer software; drug discovery services through a method of computer modeling; rental of computer programs of computer simulation; chemical analysis
GS0421Design and development of virtual reality software; scientific and technological services, namely, scientific research; scientific laboratory services; protein chemical analysis; product development of devices for protein analysis; new product design services, namely, design of devices intended for protein analysis; database design and development; scientific research conducted using databases; biological analysis of molecular anatomy; product development of devices for molecular analysis; development of computer software for big data processing; technical consulting services in the field of data analysis for biotechnological applications; technical consulting services in the field of computer software development for biotechnological applications; research in the field of biotechnology; biochemical analysis; software as a service (SAAS) services featuring software for use in the design and research of pharmaceutical preparations and compounds, used for simulation of molecular dynamics, and for use in quantum calculation in the field of pharmaceuticals and medicines; platform as a service (PAAS) featuring computer software platforms for software for use in the design and research of pharmaceutical preparations and compounds, used for simulation of molecular dynamics, and for use in quantum calculation in the field of pharmaceuticals and medicines; technical support services, namely, providing technical advice in the field of drug discovery for providing artificial intelligence based computer software; drug discovery services; research in the field of pharmacogenetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; technical consultancy relating to pharmaceutical research and development; clinical trials in medicines for others; hosting an online website featuring medical information; design of medical diagnostic apparatus and instruments; computer services, namely, computer system administration for others for remote data management of medical diagnostic instruments; technical support services, namely, troubleshooting of computer software problems in the field of medical diagnostics; research for medical products; technical consulting services in the field of testing, inspection, and research of medical products; research and development of computer software platforms in the field of artificial intelligence; development of computer software for artificial intelligence services; scientific research, namely, conducting clinical trials for others; updating and maintenance of computer software; drug discovery services through a method of computer modeling; rental of computer programs of computer simulation; chemical analysis

Trademark Filing History

DescriptionDateEvent Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB2021-02-041 REPR M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2021-02-082 NWOS I:Incoming Correspondence
APPLICATION FILING RECEIPT MAILED2021-02-123 MAFR O:Outgoing Correspondence
ASSIGNED TO EXAMINER2021-05-264 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2021-05-275 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2021-05-286 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU2021-06-017 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2021-06-018 RFCS P:
REFUSAL PROCESSED BY IB2021-06-209 RFNT P:
TEAS RESPONSE TO OFFICE ACTION RECEIVED2021-09-2810 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2021-09-2811 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2021-09-2812 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2021-09-2913 CNSA O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2021-10-1314 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2021-11-0215 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2021-11-0216 NPUB E:E-Mail
CHANGE OF NAME/ADDRESS REC'D FROM IB2021-12-1817 ADCH M:
REGISTERED-PRINCIPAL REGISTER2022-01-1818 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB2022-04-1819 FICR P:
FINAL DISPOSITION PROCESSED2022-06-2820 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB2022-06-2921 FICS P:
FINAL DECISION TRANSACTION PROCESSED BY IB2022-07-1822 FINO P:

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed